Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma

T. C. Chua, T. D. Yan, M. Deraco, O. Glehen, B. J. Moran, P. H. Sugarbaker

Research output: Contribution to journalArticle

Abstract

Background: This study was undertaken to measure survival of patients with multicystic peritoneal mesothelioma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy through a multi-institutional collaboration. Methods: A multi-institutional data registry, established by the Peritoneal Surface Oncology Group, was used to identify patients with peritoneal mesothelioma and the subgroup with multicystic tumours, treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Outcomes for this subgroup are reported. The primary endpoint was overall survival. A secondary endpoint was the incidence of treatment-related complications. Results: Of 405 patients with peritoneal mesothelioma, 26 (6·4 per cent) had multicystic tumours. There were 20 women and six men with a mean(s.d.) age of 42(12) years. The median peritoneal carcinomatosis index (PCI) was 14 (range 6-39). There was no perioperative mortality. Six patients developed grade III or IV complications. After a median follow-up of 54 (range 5-129) months, all 26 patients were still alive. Conclusion: Multicystic peritoneal mesothelioma appears to be a distinct subtype of peritoneal mesothelioma, where long-term survival may be achieved through cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Original languageEnglish
Pages (from-to)60-64
Number of pages5
JournalBritish Journal of Surgery
Volume98
Issue number1
DOIs
Publication statusPublished - Jan 2011

Fingerprint

Mesothelioma
Drug Therapy
Survival
Registries
Neoplasms
Carcinoma
Mortality
Incidence

ASJC Scopus subject areas

  • Surgery

Cite this

Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma. / Chua, T. C.; Yan, T. D.; Deraco, M.; Glehen, O.; Moran, B. J.; Sugarbaker, P. H.

In: British Journal of Surgery, Vol. 98, No. 1, 01.2011, p. 60-64.

Research output: Contribution to journalArticle

Chua, T. C. ; Yan, T. D. ; Deraco, M. ; Glehen, O. ; Moran, B. J. ; Sugarbaker, P. H. / Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma. In: British Journal of Surgery. 2011 ; Vol. 98, No. 1. pp. 60-64.
@article{376fa1a63fd74389b2448adbcc214807,
title = "Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma",
abstract = "Background: This study was undertaken to measure survival of patients with multicystic peritoneal mesothelioma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy through a multi-institutional collaboration. Methods: A multi-institutional data registry, established by the Peritoneal Surface Oncology Group, was used to identify patients with peritoneal mesothelioma and the subgroup with multicystic tumours, treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Outcomes for this subgroup are reported. The primary endpoint was overall survival. A secondary endpoint was the incidence of treatment-related complications. Results: Of 405 patients with peritoneal mesothelioma, 26 (6·4 per cent) had multicystic tumours. There were 20 women and six men with a mean(s.d.) age of 42(12) years. The median peritoneal carcinomatosis index (PCI) was 14 (range 6-39). There was no perioperative mortality. Six patients developed grade III or IV complications. After a median follow-up of 54 (range 5-129) months, all 26 patients were still alive. Conclusion: Multicystic peritoneal mesothelioma appears to be a distinct subtype of peritoneal mesothelioma, where long-term survival may be achieved through cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.",
author = "Chua, {T. C.} and Yan, {T. D.} and M. Deraco and O. Glehen and Moran, {B. J.} and Sugarbaker, {P. H.}",
year = "2011",
month = "1",
doi = "10.1002/bjs.7263",
language = "English",
volume = "98",
pages = "60--64",
journal = "British Journal of Surgery",
issn = "0007-1323",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Multi-institutional experience of diffuse intra-abdominal multicystic peritoneal mesothelioma

AU - Chua, T. C.

AU - Yan, T. D.

AU - Deraco, M.

AU - Glehen, O.

AU - Moran, B. J.

AU - Sugarbaker, P. H.

PY - 2011/1

Y1 - 2011/1

N2 - Background: This study was undertaken to measure survival of patients with multicystic peritoneal mesothelioma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy through a multi-institutional collaboration. Methods: A multi-institutional data registry, established by the Peritoneal Surface Oncology Group, was used to identify patients with peritoneal mesothelioma and the subgroup with multicystic tumours, treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Outcomes for this subgroup are reported. The primary endpoint was overall survival. A secondary endpoint was the incidence of treatment-related complications. Results: Of 405 patients with peritoneal mesothelioma, 26 (6·4 per cent) had multicystic tumours. There were 20 women and six men with a mean(s.d.) age of 42(12) years. The median peritoneal carcinomatosis index (PCI) was 14 (range 6-39). There was no perioperative mortality. Six patients developed grade III or IV complications. After a median follow-up of 54 (range 5-129) months, all 26 patients were still alive. Conclusion: Multicystic peritoneal mesothelioma appears to be a distinct subtype of peritoneal mesothelioma, where long-term survival may be achieved through cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

AB - Background: This study was undertaken to measure survival of patients with multicystic peritoneal mesothelioma treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy through a multi-institutional collaboration. Methods: A multi-institutional data registry, established by the Peritoneal Surface Oncology Group, was used to identify patients with peritoneal mesothelioma and the subgroup with multicystic tumours, treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Outcomes for this subgroup are reported. The primary endpoint was overall survival. A secondary endpoint was the incidence of treatment-related complications. Results: Of 405 patients with peritoneal mesothelioma, 26 (6·4 per cent) had multicystic tumours. There were 20 women and six men with a mean(s.d.) age of 42(12) years. The median peritoneal carcinomatosis index (PCI) was 14 (range 6-39). There was no perioperative mortality. Six patients developed grade III or IV complications. After a median follow-up of 54 (range 5-129) months, all 26 patients were still alive. Conclusion: Multicystic peritoneal mesothelioma appears to be a distinct subtype of peritoneal mesothelioma, where long-term survival may be achieved through cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

UR - http://www.scopus.com/inward/record.url?scp=78650151089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650151089&partnerID=8YFLogxK

U2 - 10.1002/bjs.7263

DO - 10.1002/bjs.7263

M3 - Article

C2 - 20872843

AN - SCOPUS:78650151089

VL - 98

SP - 60

EP - 64

JO - British Journal of Surgery

JF - British Journal of Surgery

SN - 0007-1323

IS - 1

ER -